Infectious Diseases

Filters3 filters applied

Status

Expression of concern
Corrected
No notice
From publisher notices and Retraction Watch. Not checked means nobody has looked yet.

Year

Readable here

Study type

Licence

29 papersQuestions on this topic

2 filters appliedStatus: Corrected Readable here: At least an abstract Clear all

Corrected
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
Utkarsh Agrawal, Stuart Bedston, Colin McCowan et al. · The Lancet · 2022
Abstract only
Corrected
The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic
Michael Worobey, Joshua I. Levy, Lorena Malpica Serrano et al. · Science · 2022
Full textCC BY
Corrected
Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission
Bradley Pickering, Oliver Lung, Finlay Maguire et al. · Nature Microbiology · 2022
Full textCC BY
Corrected
Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
Zhen Cui, Pan Liu, Nan Wang et al. · Cell · 2022
Abstract only
Corrected
Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater
Davida S. Smyth, Monica Trujillo, Devon A. Gregory et al. · Nature Communications · 2022
Full textCC BY
Corrected
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Bégin, Jeannie Callum, Erin Jamula et al. · Nature Medicine · 2021 · Randomised trial
Full textCC BY
Corrected
The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis
Elizabeth A Cromwell, Chris A Schmidt, Kevin T Kwong et al. · The Lancet Global Health · 2020
Full textCC BY
Corrected
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
Wen Wen, Wenru Su, Hao Tang et al. · Cell Discovery · 2020
Full textCC BY
Corrected
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
Jiandong Huo, Yuguang Zhao, Jingshan Ren et al. · Cell Host & Microbe · 2020
Abstract only
Corrected
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou, Yan Liu, Xiaobo Lei et al. · Nature Communications · 2020
Full textCC BY
Corrected
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
Li Tan, Qi Wang, Duanyang Zhang et al. · Signal Transduction and Targeted Therapy · 2020
Full textCC BY
Corrected
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Mark Ainsworth, Monique Andersson, Kathryn Auckland et al. · The Lancet Infectious Diseases · 2020
Abstract only
Corrected
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Pedro M Folegatti, Mustapha Bittaye, Amy Flaxman et al. · The Lancet Infectious Diseases · 2020
Abstract only
Corrected
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
Antonio E. Muruato, Camila R. Fontes-Garfias, Ping Ren et al. · Nature Communications · 2020
Abstract only
Corrected
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
Ping Liu, Jing-Zhe Jiang, Xiu-Feng Wan et al. · PLOS Pathogens · 2020
Full textCC BY
Corrected
Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study
Luke W Meredith, William L Hamilton, Ben Warne et al. · The Lancet Infectious Diseases · 2020
Abstract only
Corrected
Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
Anika Singanayagam, Monika Patel, Andre Charlett et al. · Eurosurveillance · 2020
Full textCC BY
Corrected
Diagnosing COVID-19-associated pulmonary aspergillosis
Paul E Verweij, Jean-Pierre Gangneux, Matteo Bassetti et al. · The Lancet Microbe · 2020
Abstract only
Corrected
IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure
Lenette L. Lu, Malisa T. Smith, Krystle K. Q. Yu et al. · Nature Medicine · 2019
Full textCC BY
Corrected
Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis
Robert N. Kirchdoerfer, Nianshuang Wang, Jesper Pallesen et al. · Scientific Reports · 2018
Abstract only